Altered endocannabinoid system gene expression in inflammatory bowel disease mucosa: New perspectives in inflammatory bowel disease management

Key Points

• A notable impairment of the endocannabinoid system was found in inflammatory bowel disease.
• The study highlights the potential of cannabinoids as a therapeutic approach in managing inflammatory bowel disease.
• Further analyses on larger cohorts are necessary for understanding the gene expression changes.
• The findings suggest new perspectives for future treatment modalities in managing inflammatory bowel disease.